| 1 |
Cetuximab for the Treatment of Colorectal Cancer
Derek J. Jonker, Chris J. O’Callaghan, Christos Stelios Karapetis et al. · New England Journal of Medicine
Open access |
14 Nov 2007 |
1,815 |
| 2 |
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients
Randy S. Wax, Michael D. Christian · Canadian Journal of Anesthesia/Journal canadien d anesthésie
Open access |
12 Feb 2020 |
1,061 |
| 3 |
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
Ángel Crespo López, Jose Angel Lorente, Jay S. Steingrub et al. · Critical Care Medicine
|
2004 |
925 |
| 4 |
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
Charles S. Fuchs, John Lindsay Marshall, Edith Peterson Mitchell et al. · Journal of Clinical Oncology
|
18 Oct 2007 |
861 |
| 5 |
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al. · New England Journal of Medicine
Open access |
4 Dec 2018 |
858 |
| 6 |
Systemic lupus erythematosus
Larissa Lisnevskaia, Grainne M. Murphy, David Alan Isenberg · The Lancet
|
31 May 2014 |
745 |
| 7 |
Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs
Irena Nulman, JOANNE F. ROVET, Donna Eileen Stewart et al. · New England Journal of Medicine
Open access |
23 Jan 1997 |
581 |
| 8 |
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
Hope S. Rugo et al. · JAMA Oncology
Open access |
23 Jan 2021 |
353 |
| 9 |
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas
Arkadiusz Piotrowski et al. · Nature Genetics
Open access |
22 Dec 2013 |
323 |
| 10 |
Do Intensivist Staffing Patterns Influence Hospital Mortality Following ICU Admission? A Systematic Review and Meta-Analyses*
Mary Elizabeth Wilcox, Christopher A. K. Y. Chong, Daniel J. Niven et al. · Critical Care Medicine
Review |
6 Aug 2013 |
321 |
| 11 |
ACVIM Consensus Statement on Therapeutic Antimicrobial Use in Animals and Antimicrobial Resistance
J. Scott Weese, Steeve Giguère, Luca Guardabassi et al. · Journal of Veterinary Internal Medicine
Open access |
Mar 2015 |
299 |
| 12 |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin et al. · Nature Medicine
Open access629 authors |
9 Sep 2021 |
275 |
| 13 |
Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study
Anthony D. Bai, Adrienne Showler, Lisa D. Burry et al. · Clinical Infectious Diseases
|
20 Feb 2015 |
264 |
| 14 |
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025
Bernard J. Escudier, Robert John Motzer, Padmanee Sharma et al. · European Urology
|
12 Apr 2017 |
243 |
| 15 |
On the Origin of the Treponematoses: A Phylogenetic Approach
Kristin Nicole Harper, Paolo Ocampo, Bret M. Steiner et al. · PLoS neglected tropical diseases
Open access |
14 Jan 2008 |
224 |
| 16 |
Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Andrew Benko, Margaret Fraser-Hill, Peter Magner et al. · PubMed
|
Apr 2007 |
221 |
| 17 |
Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis
Gihad E. NESRALLAH et al. · Journal of the American Society of Nephrology
Open access |
23 Feb 2012 |
218 |
| 18 |
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Giorgio V. Scagliotti, Maciej Jerzy Krzakowski, Aleksandra Szczęsna et al. · Journal of Clinical Oncology
|
8 May 2012 |
211 |
| 19 |
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
Andra Valentina Krauze, Sten D. Myrehaug, Michael G. Chang et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
2 May 2015 |
206 |
| 20 |
Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies
Andrew R. MacRae, Peter A. Kavsak, Viliam Lustig et al. · Clinical Chemistry
|
23 Mar 2006 |
202 |
| 21 |
National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States
Geoffrey C. Nguyen, Christopher A. K. Y. Chong, Rachel Y. Chong · Journal of Crohn s and Colitis
|
24 Sep 2013 |
196 |
| 22 |
Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing
Dea Shahinas, Michael Silverman, Taylor Sittler et al. · mBio
Open access |
24 Oct 2012 |
195 |
| 23 |
Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature
Chelsea Lowther, Gregory Costain, Dimitri James Stavropoulos et al. · Genetics in Medicine
Open access |
31 Jul 2014 |
194 |
| 24 |
Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group
Lawrence A. Leiter et al. · Canadian Journal of Cardiology
|
Mar 2011 |
191 |
| 25 |
Evidence for a Turner Syndrome Locus or Loci at Xp11.2-p22.1
Andrew R. Zinn, Vijay S. Tonk, Zhong Chen et al. · The American Journal of Human Genetics
Open access |
Dec 1998 |
188 |
| 26 |
An empirical test of the Nursing Role Effectiveness Model
Diane Irvine Doran, Souraya Sidani, Margaret Keatings et al. · Journal of Advanced Nursing
|
13 Mar 2002 |
187 |
| 27 |
Tables for clinicians to use to convert WAIS-R short forms
Barry H. Brooker, James J. Cyr · Journal of Clinical Psychology
|
Nov 1986 |
181 |
| 28 |
Fertility Desires and Intentions of HIV-Positive Women of Reproductive Age in Ontario, Canada: A Cross-Sectional Study
Mona Rafik Loutfy, Trevor Adam Hart, Saira S. Mohammed et al. · PLoS ONE
Open access |
4 Dec 2009 |
174 |
| 29 |
Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty
Brian G. Feagan, Cindy J. Wong, Alexandra Kirkley et al. · Annals of Internal Medicine
|
5 Dec 2000 |
170 |
| 30 |
17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis
Jacques Emile Rioux, Margaret Devlin, Morrie M. Gelfand et al. · Menopause The Journal of The North American Menopause Society
|
25 Oct 2018 |
168 |
| 31 |
Canadian Association of Radiologists Consensus Guidelines for the Prevention of Contrast-Induced Nephropathy: Update 2012
Richard J Owen, Swapnil S. Hiremath, Andy Myers et al. · Canadian Association of Radiologists Journal
|
20 Feb 2014 |
164 |
| 32 |
Trans people's experiences with assisted reproduction services: a qualitative study
Sarah James-Abra, Lesley A. Tarasoff, d. green et al. · Human Reproduction
|
22 Apr 2015 |
153 |
| 33 |
Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT)
Charmaine E. Lok et al. · American Journal of Kidney Diseases
Open access |
14 Jun 2017 |
146 |
| 34 |
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline
Sam D. Shemie et al. · Canadian Journal of Anesthesia/Journal canadien d anesthésie
Open access |
Apr 2023 |
139 |
| 35 |
Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction
Lee H. Sterling, Shannon M. Fernando, Robert Talarico et al. · Journal of the American College of Cardiology
Open access |
28 Aug 2023 |
133 |
| 36 |
A Model to Guide Patient and Family Care
Frank D. Ferris, Heather Balfour, Karen Lee Bowen et al. · Journal of Pain and Symptom Management
Open access |
Aug 2002 |
132 |
| 37 |
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
Santiago Ponce Aix et al. · The Lancet Respiratory Medicine
Open access |
14 Oct 2022 |
125 |
| 38 |
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti et al. · BMC Infectious Diseases
ReviewOpen access |
31 Jan 2022 |
125 |
| 39 |
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment
Grainne M. Murphy, Larissa Lisnevskaia, David Alan Isenberg · The Lancet
|
Aug 2013 |
125 |
| 40 |
HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction
Eszter Papp, Hakimeh Mohammadi, Mona Rafik Loutfy et al. · The Journal of Infectious Diseases
Open access |
16 Jul 2014 |
124 |
| 41 |
Salvage after Severe Lower-Extremity Trauma: Are the Outcomes Worth the Means?
Alexander Bee Dagum, Andrew K. Best, Emil H. Schemitsch et al. · Plastic & Reconstructive Surgery
|
Apr 1999 |
122 |
| 42 |
Chemotherapy dose reduction and delay in clinical practice
José Chang · European Journal of Cancer
|
Apr 2000 |
118 |
| 43 |
Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome
Wendy Y. Craig, James E. Haddow, Glenn E. Palomaki et al. · Prenatal Diagnosis
|
11 Jul 2006 |
112 |
| 44 |
Age-related differences in the management and outcome of patients with acute coronary syndromes
Raymond T. Yan, Andrew Tze-Kay Yan, Mary Tan et al. · American Heart Journal
|
27 Jan 2006 |
111 |
| 45 |
Does Stevens’s Power Law for Brightness Extend to Perceptual Brightness Averaging?
Ben Bauer · The Psychological Record
|
Apr 2009 |
107 |
| 46 |
Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma
Kenneth R. Chapman, Piyush M. Patel, Anthony D D’Urzo et al. · Allergy
|
20 Dec 2004 |
104 |
| 47 |
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
Bernard J. Escudier, Marc Dror Michaelson, Robert John Motzer et al. · British Journal of Cancer
Open access |
13 May 2014 |
102 |
| 48 |
CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems
Sébastien Chénier, Grace Yoon, Bob Argiropoulos et al. · Journal of Neurodevelopmental Disorders
Open access |
22 Apr 2014 |
96 |
| 49 |
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer
Martin Reck, Thomas Wehler, Francesco Orlandi et al. · Journal of Clinical Oncology
Open access |
27 May 2020 |
95 |
| 50 |
How Well Do Guidelines Incorporate Evidence on Patient Preferences?
Christopher A. K. Y. Chong, Ing-je Chen, Gary Naglie et al. · Journal of General Internal Medicine
Open access |
22 Apr 2009 |
91 |